Study: 42% of Robotic Prostatectomy Marketing Did Not Include Risks

Forty-two percent of websites that mentioned robotic prostatectomy did not mention associated risks, according to a study in Health Affairs.

Advertisement

Researchers studied internet marketing of robotic surgery to remove a cancerous prostate. They found that many sites claimed benefits that were not supported by evidence. In addition, the majority of sites on the procedure were from hospitals and physicians, which may seem more objective to consumers, according to the study.

The authors suggested the government and medical societies promote the use of balanced educational material when marketing a medical procedure or technology.

More Articles on Hospital Oncology:

Study: Cancer Patients’ Higher Survival in U.S. vs. Europe “Worth” the Extra Costs
High Tea at Taussig Cancer Institute: Improving Patients’ Experience at Cleveland Clinic

Study: Chemotherapy Patient Care Costs 24% More in Hospital Outpatient Setting Than in Physician Office

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.